Adam M. LaBaff

1.5k total citations
8 papers, 894 citations indexed

About

Adam M. LaBaff is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Adam M. LaBaff has authored 8 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Cancer Research. Recurrent topics in Adam M. LaBaff's work include Cancer Cells and Metastasis (4 papers), Histone Deacetylase Inhibitors Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Adam M. LaBaff is often cited by papers focused on Cancer Cells and Metastasis (4 papers), Histone Deacetylase Inhibitors Research (2 papers) and Epigenetics and DNA Methylation (2 papers). Adam M. LaBaff collaborates with scholars based in United States, Taiwan and Japan. Adam M. LaBaff's co-authors include Mien‐Chie Hung, Jennifer L. Hsu, Chia‐Wei Li, Weiya Xia, Lei Nie, Hirohito Yamaguchi, Seung-Oe Lim, Longfei Huo, Gabriel N. Hortobágyi and Hsing‐Ju Wu and has published in prestigious journals such as Cancer Research, Oncogene and Biochemical and Biophysical Research Communications.

In The Last Decade

Adam M. LaBaff

8 papers receiving 883 citations

Peers

Adam M. LaBaff

MB

CR

ONCOL

IMMUN

EPIDE

Yi Sang China

Norihisa Hanada Japan

Yongping Cui China

Stefania Zona United Kingdom

Hanxiang Zhan China

Ellen P.S. Man Hong Kong

Gloria Manzotti Italy

Mingjing Shen China

Junhu Wan China

Yi Sang China

Adam M. LaBaff

885 ×1.5

MB

433 ×1.2

CR

220 ×0.6

ONCOL

98 ×1.0

IMMUN

67 ×1.0

EPIDE

Citations per year, relative to Adam M. LaBaff Adam M. LaBaff (= 1×) peers Yi Sang

Countries citing papers authored by Adam M. LaBaff

Since Specialization

Citations

This map shows the geographic impact of Adam M. LaBaff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam M. LaBaff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam M. LaBaff more than expected).

Fields of papers citing papers by Adam M. LaBaff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adam M. LaBaff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam M. LaBaff. The network helps show where Adam M. LaBaff may publish in the future.

Co-authorship network of co-authors of Adam M. LaBaff

This figure shows the co-authorship network connecting the top 25 collaborators of Adam M. LaBaff. A scholar is included among the top collaborators of Adam M. LaBaff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adam M. LaBaff. Adam M. LaBaff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Werden, Steven J., Nathalie Sphyris, Tapasree Roy Sarkar, et al.. (2016). Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth. Oncogene. 35(46). 5977–5988. 44 indexed citations

2.

Ko, How-Wen, Heng‐Huan Lee, Longfei Huo, et al.. (2016). GSK3β inactivation promotes the oncogenic functions of EZH2 and enhances methylation of H3K27 in human breast cancers. Oncotarget. 7(35). 57131–57144. 34 indexed citations

3.

Yang, Cheng, Adam M. LaBaff, Yongkun Wei, et al.. (2015). Phosphorylation of EZH2 at T416 by CDK2 contributes to the malignancy of triple negative breast cancers.. PubMed. 7(6). 1009–20. 40 indexed citations

4.

Shen, Jia, Weiya Xia, Adam M. LaBaff, et al.. (2014). MDM2-mediated degradation of SIRT6 phosphorylated by AKT1 promotes tumorigenesis and trastuzumab resistance in breast cancer. Science Signaling. 7(336). ra71–ra71. 76 indexed citations

5.

Spaeth, Erika L., Adam M. LaBaff, Bryan P. Toole, et al.. (2013). Mesenchymal CD44 Expression Contributes to the Acquisition of an Activated Fibroblast Phenotype via TWIST Activation in the Tumor Microenvironment. Cancer Research. 73(17). 5347–5359. 74 indexed citations

6.

Li, Chia‐Wei, Weiya Xia, Longfei Huo, et al.. (2012). Epithelial–Mesenchymal Transition Induced by TNF-α Requires NF-κB–Mediated Transcriptional Upregulation of Twist1. Cancer Research. 72(5). 1290–1300. 389 indexed citations

7.

Nie, Lei, Hsing‐Ju Wu, Jung-Mao Hsu, et al.. (2012). Long non-coding RNAs: versatile master regulators of gene expression and crucial players in cancer.. PubMed. 4(2). 127–50. 203 indexed citations

8.

Song, Hui, Chia‐Wei Li, Adam M. LaBaff, et al.. (2010). Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors. Biochemical and Biophysical Research Communications. 404(1). 68–73. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact